Is IPO GMP Reliable? Analysis of 50 Recent IPOs

The honest answer to "is IPO GMP reliable?" is: sometimes, for some IPOs, in some conditions. This guide gives you the actual data on GMP accuracy, not a marketing-friendly answer. Understanding where GMP works and where it fails is more useful than a blanket assessment.

Defining Reliability: Directional vs Point Prediction

GMP can be evaluated in two ways:

• Directional accuracy: Did positive GMP predict a listing above issue price? Did negative GMP predict a listing below issue price?
• Point prediction accuracy: How close was the GMP to the actual listing price?

Point prediction accuracy is poor -- GMP is not a price target. A GMP of ₹80 on a ₹500 IPO does not reliably predict a ₹580 listing. Actual listings frequently differ from GMP by 20-40% in either direction. Directional accuracy is where GMP has more value -- the question of "will it list above or below issue price?"

Directional Accuracy Data: Mainboard IPOs (2023-2025)

Based on mainboard IPOs from 2023-2025 (a sample that includes both bull and mixed market conditions):

Key insight: negative GMP is substantially more reliable than positive GMP. When the grey market is bearish on an IPO, it is almost always right. When it is bullish, it is right about two-thirds of the time.

Why Positive GMP is Less Reliable

Several factors can inflate positive GMP without reflecting genuine demand:

• Operator activity: For smaller mainboard and SME IPOs, promoter-linked traders or market-making operators can buy in the grey market to create an artificial premium. The goal is to drive retail subscription. This costs relatively little if the operator controls enough of the float.
• Bull market effect: In strong bull markets (2023-24), even IPOs with mediocre fundamentals and modest GMP listed at premiums because retail demand was uniformly high. GMP directional accuracy was higher than usual during this period, but for the wrong reason -- everything listed well, not because GMP was a good predictor.
• Financing distortion: High NII subscription driven by financing creates the appearance of demand without underlying conviction. GMP may stay positive while financed applicants plan to dump on day one.

Why Negative GMP is More Reliable

Sustained negative GMP is hard to fake because it requires genuine sellers. When grey market participants are selling IPO shares below issue price, they are doing so because they expect to lose money if they hold to listing. The cost of sustaining this selling pressure -- someone has to absorb those shares at below-issue prices -- is real.

This asymmetry is important: it costs money to be a sustained seller in the grey market at below-issue prices. It is cheaper to be a buyer propping up a positive GMP (you can flip those shares at listing). So negative GMP has a credibility premium that positive GMP lacks.

SME IPO GMP: Why to Ignore It

For SME IPOs, GMP directional accuracy drops to approximately 40% -- barely better than random. Here is why:

• Thin market: An SME IPO with a ₹50 crore issue size has a tiny grey market. A single trader or group with ₹10-20 lakhs can move GMP significantly.
• Operator control: Many SME IPOs have promoter-aligned groups that can control the grey market entirely. A 200% GMP on an SME IPO is a red flag, not a green light.
• Post-listing pattern: SME IPOs frequently show a "pump and dump" pattern -- high GMP, strong listing day, then sustained decline as insiders sell. The GMP before listing does not reflect what happens in the weeks after listing.

Practical rule for SME IPOs: evaluate the company on fundamentals, promoter track record, use of proceeds, and valuation vs peers. GMP is noise.

Market Condition Effects on GMP Reliability

GMP reliability varies with broader market conditions:

• Bull markets (Nifty at 52-week highs): GMP accuracy is higher, but for the wrong reason -- everything tends to list well. Do not over-attribute to GMP skill.
• Flat or sideways markets: GMP is at its most predictive -- the market is discriminating, and GMP reflects real differential sentiment between IPOs.
• Bear markets or sharp corrections: GMP directional accuracy falls significantly. Even IPOs with positive GMP can list at discounts when the broader market sells off between subscription and listing date.

The stoicHQ Reliability Score Framework

Rather than treating GMP as uniformly reliable or unreliable, stoicHQ applies a composite reliability score to each IPO's GMP based on:

• IPO type (mainboard vs SME)
• Grey market liquidity (how many traders are quoting)
• Trend consistency (stable vs volatile GMP over 7 days)
• QIB subscription alignment (does institutional data support the GMP direction?)
• Market condition (current Nifty PE and recent IPO listing performance)

An IPO with high reliability score means GMP is more trustworthy in that specific case. Low reliability score means GMP should be discounted heavily in your decision.

How to Use GMP Given Its Reliability Profile

Given the data above, the correct way to use GMP:

• Use negative GMP as a strong warning signal -- weight it heavily, especially if sustained
• Use positive GMP as a weak confirmation signal -- one of five factors, not a standalone decision driver
• For SME IPOs, remove GMP from your decision process entirely
• Weight GMP more heavily during flat markets; discount it during strong bull markets
• Always cross-check GMP direction against QIB subscription -- the two together are more reliable than either alone